Genomic Health Announces Preliminary Results From A Study Of Oncotype DX(TM) In Node-Positive Breast Cancer Patients

Genomic Health, Inc. (Nasdaq: GHDX) announced encouraging results from a study of Oncotype DX in postmenopausal women with node-positive, hormone receptor positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute clinical trials cooperative group. [click link for full article]

More: continued here

Comments are closed.



Free prescriptions rx - : Free prescriptions rx
Healthy Recipes 4 All - : Healthy Recipes 4 All
My RX Pharmacy - Buy Online: My RX pharmacy
Pills Value - : Pills Value
RX Pills Store - Buy Drugs: RX pills sotre
Rx Pill Pharmacy - Rx Pill Pharmacy: Pharmacy for RX pill
Yo Durgs - Buy Your Pills: Getting drugs online gives you many advantages like privacy, saving money and saving TIME
Privacy plus prescriptions - : Privacy plus prescriptions
Rx Meds Online - Rx Meds Online: Medical Rx online
The world pharmacy - : The world pharmacy
Latest News...